154 related articles for article (PubMed ID: 30807688)
1. HapMap-based study: CYP2A13 may be a potential key metabolic enzyme gene in the carcinogenesis of lung cancer in non-smokers.
Hua F; Guo Y; Sun Q; Yang L; Gao F
Thorac Cancer; 2019 Apr; 10(4):601-606. PubMed ID: 30807688
[TBL] [Abstract][Full Text] [Related]
2. HapMap-based study on the association between MPO and GSTP1 gene polymorphisms and lung cancer susceptibility in Chinese Han population.
Gu JD; Hua F; Mei CR; Zheng DJ; Wang GF; Zhou QH
Acta Pharmacol Sin; 2014 May; 35(5):636-44. PubMed ID: 24786234
[TBL] [Abstract][Full Text] [Related]
3. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.
Wang H; Tan W; Hao B; Miao X; Zhou G; He F; Lin D
Cancer Res; 2003 Nov; 63(22):8057-61. PubMed ID: 14633739
[TBL] [Abstract][Full Text] [Related]
4. CYP2A13 Genetic Polymorphisms in Relation to the Risk of Bladder Cancer in Japanese Smokers.
Kumondai M; Hosono H; Orikasa K; Arai Y; Arai T; Sugimura H; Ozono S; Sugiyama T; Takayama T; Sasaki T; Hirasawa N; Hiratsuka M
Biol Pharm Bull; 2016; 39(10):1683-1686. PubMed ID: 27725446
[TBL] [Abstract][Full Text] [Related]
5. Association between cancer risk and drug-metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in cases of lung cancer in Japan.
Tamaki Y; Arai T; Sugimura H; Sasaki T; Honda M; Muroi Y; Matsubara Y; Kanno S; Ishikawa M; Hirasawa N; Hiratsuka M
Drug Metab Pharmacokinet; 2011; 26(5):516-22. PubMed ID: 21791872
[TBL] [Abstract][Full Text] [Related]
6. LncRNA NEAT1 polymorphisms and lung cancer susceptibility in a Chinese Northeast Han Population: A case-control study.
Wang S; Cui Z; Li H; Li J; Lv X; Yang Z; Gao M; Bi Y; Zhang Z; Zhou B; Yin Z
Pathol Res Pract; 2019 Dec; 215(12):152723. PubMed ID: 31704150
[TBL] [Abstract][Full Text] [Related]
7. HapMap-based study identifies risk sub-region on chromosome 19q13.3 in relation to lung cancer among Chinese.
Yin J; Vogel U; Wang H; Ma Y; Wang C; Liang D; Liu J; Yue L; Zhao Y; Ma J
Cancer Epidemiol; 2013 Dec; 37(6):923-9. PubMed ID: 24140460
[TBL] [Abstract][Full Text] [Related]
8. CYP2A6, CYP1A1, and CYP2D6 polymorphisms in lung cancer patients from central south China.
Huang FM; Chen HC; Khan MA; Yang FL; Wan XX; Xu AH; Ou-yang FD; Zhang DZ
Med Oncol; 2013 Jun; 30(2):521. PubMed ID: 23471717
[TBL] [Abstract][Full Text] [Related]
9. Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population.
Ezzeldin N; El-Lebedy D; Darwish A; El Bastawisy A; Abd Elaziz SH; Hassan MM; Saad-Hussein A
BMC Cancer; 2018 May; 18(1):525. PubMed ID: 29724170
[TBL] [Abstract][Full Text] [Related]
10. Association of PSMA4 polymorphisms with lung cancer susceptibility and response to cisplatin-based chemotherapy in a Chinese Han population.
Wang T; Chen T; Thakur A; Liang Y; Gao L; Zhang S; Tian Y; Jin T; Liu JJ; Chen M
Clin Transl Oncol; 2015 Jul; 17(7):564-9. PubMed ID: 25744645
[TBL] [Abstract][Full Text] [Related]
11. Tag SNPs in complement receptor-1 contribute to the susceptibility to non-small cell lung cancer.
Yu X; Rao J; Lin J; Zhang Z; Cao L; Zhang X
Mol Cancer; 2014 Mar; 13():56. PubMed ID: 24621201
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 15q25 (CHRNA3-CHRNB4) Variation Indirectly Impacts Lung Cancer Risk in Chinese Males.
Zhang Y; Jiang M; Li Q; Liang W; He Q; Chen W; He J
PLoS One; 2016; 11(3):e0149946. PubMed ID: 26942719
[TBL] [Abstract][Full Text] [Related]
13. [Human chromosome 8p11 (CHRNB3-CHRNA6) region gene polymorphisms and susceptibility to lung cancer in Chinese Han population].
Zhang XB; Zhao ZH; Chen HY; Wang JC; Qian J; Yang YJ; Wei QY; Huang J; Lu DR
Yi Chuan; 2011 Aug; 33(8):886-94. PubMed ID: 21831805
[TBL] [Abstract][Full Text] [Related]
14. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
[TBL] [Abstract][Full Text] [Related]
15. CYP2A6 genetic polymorphism is associated with decreased susceptibility to squamous cell lung cancer in Japanese smokers.
Hosono H; Kumondai M; Arai T; Sugimura H; Sasaki T; Hirasawa N; Hiratsuka M
Drug Metab Pharmacokinet; 2015 Aug; 30(4):263-8. PubMed ID: 26091970
[TBL] [Abstract][Full Text] [Related]
16. Tag SNPs of CFI contributed to the susceptibility for non-small cell lung cancer in Chinese population.
Liu Y; Bi Y; Lin J; Cao L; He B; Zhang Z; Cui Y; Zhang X
Tumour Biol; 2015 Mar; 36(3):1955-62. PubMed ID: 25394898
[TBL] [Abstract][Full Text] [Related]
17. CYP3A4 genetic variants are associated with susceptibility of non-small cell lung cancer in a Shaanxi Han population.
Jia Z; Zhou W; Zhang G; Fu J; Li D; Ren L
Genomics; 2020 Sep; 112(5):3465-3472. PubMed ID: 32464168
[TBL] [Abstract][Full Text] [Related]
18. Novel single nucleotide polymorphism of the CYP2A13 gene in Japanese individuals.
Tamaki Y; Honda M; Muroi Y; Arai T; Sugimura H; Matsubara Y; Kanno S; Ishikawa M; Hirasawa N; Hiratsuka M
Drug Metab Pharmacokinet; 2011; 26(5):544-7. PubMed ID: 21606606
[TBL] [Abstract][Full Text] [Related]
19. [Interference of homologous sequences on the SNP study of CYP2A13 gene].
Hua F; Wan H; Mei C; Zheng D; Sun L; Chen J; Liu H; Zhou Q
Zhongguo Fei Ai Za Zhi; 2010 Feb; 13(2):94-7. PubMed ID: 20673498
[TBL] [Abstract][Full Text] [Related]
20. Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract.
Chiang HC; Wang CK; Tsou TC
Respiration; 2012; 84(4):319-26. PubMed ID: 22890016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
